HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $184,536 | -4.6% | 259,910 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $193,425 | +2.5% | 259,910 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $188,617 | -25.2% | 259,910 | 0.0% | 0.01% | -30.0% |
| Q3 2022 | $252,000 | -49.2% | 259,910 | 0.0% | 0.01% | -47.4% |
| Q2 2022 | $496,000 | -61.6% | 259,910 | 0.0% | 0.02% | -57.8% |
| Q1 2022 | $1,292,000 | -26.9% | 259,910 | +144.2% | 0.04% | -27.4% |
| Q4 2020 | $1,768,000 | -2.2% | 106,419 | 0.0% | 0.06% | -8.8% |
| Q3 2020 | $1,808,000 | – | 106,419 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
| MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
| Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
| Artal Group S.A. | 1,000,000 | $744 | 0.04% |
| Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
| Orbimed Advisors | 621,218 | $462,310 | 0.01% |
| Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
| CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |